Status:
WITHDRAWN
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Lead Sponsor:
University of Chicago
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-appro...
Eligibility Criteria
Inclusion
- 18-95 years old
- Diagnosied with actinic keratoses.
Exclusion
- Patients who have had Isotretinoin therapy less that 1 year prior to screening.
- Patients who have an adverse reaction to light exposure (for example photo- exacerbated seizures).
- History of porphyria
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00814528
Start Date
November 1 2007
End Date
September 1 2009
Last Update
September 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637